Edwards Lifesciences Corp.

NYS : EW
Pharmaceuticals
Irvine California
2011 Revenue (US$ Millions)$1,679
2010 Revenue (US$ Millions)$1,447
Revenue Growth (%)16.01%
Net Income (US$ Millions)$237
Common Shares Outstanding (Millions)$114
Earnings Per Share (US$)$1.98
Earnings Per Share Growth (%)8.20%
Price To Earnings Ratio44.14
Total Equity (US$ Millions)$1,338
Profit Growth (%)8.58
Profit Margin (%)14.10%
Return On Equity (%)18.09%
Long Term Debt (US$ Millions)$150
Debt To Equity Ratio (%)0.11%
Market Capitalization (US$ Millions)$8,067
Total Assets (US$ Millions)$1,981
Return on Assets (%)13.39
Current Assets (US$ Millions)$1,169
Inventories (US$ Millions)$261
Current Liabilities (US$ Millions)$335
Cost of Goods Sold (US$ Millions)$490
Asset Turnover0.85
Inventory Turnover2.11